NCT03968744View on ClinicalTrials.gov

Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease

PHASE4RecruitingINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

February 18, 2019

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Idiopathic Parkinson's Disease (at Later Stage)
Interventions
DRUG

Safinamide

Safinamide taken per Os for 12 weeks

Trial Locations (1)

6900

RECRUITING

Neurocenter of Southern Switzerland - Ente Ospedaliero Cantonale (EOC), Lugano

All Listed Sponsors
collaborator

Clinical Trial Unit Ente Ospedaliero Cantonale

OTHER

lead

Alain Kaelin

OTHER